| 000 | 02556 a2200709 4500 | ||
|---|---|---|---|
| 005 | 20250514184554.0 | ||
| 264 | 0 | _c20040513 | |
| 008 | 200405s 0 0 eng d | ||
| 022 | _a0902-4441 | ||
| 024 | 7 |
_a10.1046/j.0902-4441.2003.00205.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKyrtsonis, Maria-Christina | |
| 245 | 0 | 0 |
_aSerum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease. _h[electronic resource] |
| 260 |
_bEuropean journal of haematology _cApr 2004 |
||
| 300 |
_a252-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aBone Resorption _xblood |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
| 650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xblood |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGlycoproteins _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLife Tables |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelphalan _xadministration & dosage |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xblood |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xblood |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xblood |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xblood |
| 650 | 0 | 4 | _aOsteoprotegerin |
| 650 | 0 | 4 | _aPamidronate |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProteoglycans _xblood |
| 650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xblood |
| 650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aSyndecan-1 |
| 650 | 0 | 4 | _aSyndecans |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 650 | 0 | 4 |
_abeta 2-Microglobulin _xanalysis |
| 700 | 1 | _aVassilakopoulos, Theodoros P | |
| 700 | 1 | _aSiakantaris, Marina P | |
| 700 | 1 | _aKokoris, Styliani I | |
| 700 | 1 | _aGribabis, Despina A | |
| 700 | 1 | _aDimopoulou, Maria N | |
| 700 | 1 | _aAngelopoulou, Maria K | |
| 700 | 1 | _aPangalis, Gerassimos A | |
| 773 | 0 |
_tEuropean journal of haematology _gvol. 72 _gno. 4 _gp. 252-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.0902-4441.2003.00205.x _zAvailable from publisher's website |
| 999 |
_c14802856 _d14802856 |
||